Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR3 | O14843 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | CA12 | O43570 | 5/20 | 0.32 |
| ▸ | CA1 | P00915 | 5/20 | 0.32 |
| ▸ | CA2 | P00918 | 5/20 | 0.32 |
| ▸ | CA9 | Q16790 | 5/20 | 0.32 |
| ▸ | EHMT2 | Q96KQ7 | 3/20 | 0.32 |
| ▸ | EHMT1 | Q9H9B1 | 3/20 | 0.32 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.32 |
| ▸ | HTT | P42858 | 2/20 | 0.32 |
| ▸ | GSDMD | P57764 | 2/20 | 0.32 |
| ▸ | CA4 | P22748 | 2/20 | 0.32 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | PHGDH | O43175 | 1/20 | 0.30 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.30 |
| ▸ | GMNN | O75496 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10768078 | 1.00 | — | — | |
| SCHEMBL300185 | 1.00 | FFAR3 (0.43) | FFAR3ALDH1A1CYP3A4TDP1TSHR | |
| SCHEMBL28909413 | 1.00 | FFAR3 (0.43) | FFAR3ALDH1A1CYP3A4TDP1TSHR | |
| SCHEMBL111807 | 1.00 | — | — | |
| Ethane SCHEMBL5581157 | 0.95 | FFAR3 (0.40) | FFAR3ALDH1A1CYP3A4TDP1TSHR | |
| Fluoride SCHEMBL11039310 | 0.95 | — | — | |
| Hydrochloric Acid SCHEMBL18185340 | 0.95 | FFAR3 (0.40) | FFAR3ALDH1A1CYP3A4TDP1TSHR | |
| Methane SCHEMBL9008507 | 0.95 | FFAR3 (0.40) | FFAR3ALDH1A1CYP3A4TDP1TSHR | |
| SCHEMBL4165623 | 0.95 | FFAR3 (0.40) | FFAR3ALDH1A1CYP3A4TDP1TSHR | |
| SCHEMBL28959747 | 0.95 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 210 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2014139979-A1 | QUANTUM DOT IN SITU HYBRIDIZATION | VENTANA MEDICAL SYSTEMS, INC. (US) | 2014-09-18 | — | — | WO | claimed |
| EP-2126584-B1 | DIRECT MASS SPECTROMETRIC ANALYSIS OF DRUG CANDIDATES TARGETING PROTEIN COMPLEXES | COVALX AG (CH) | 2012-12-19 | — | — | EP | claimed |
| EP-2095129-B1 | DIRECT MASS SPECTROMETRIC ANALYSIS OF SELF-AGGREGATES OF THERAPEUTIC PROTEINS | COVALX AG (SE) | 2011-02-23 | — | — | EP | claimed |
| EP-1886143-A1 | BIOLOGICAL INDICATOR | Steris, Inc. (US) | 2008-02-13 | — | — | EP | claimed |
| WO-2007046865-A1 | BIOLOGICAL INDICATOR | STERIS, INC. (US) | 2007-04-26 | — | — | WO | claimed |
| WO-2005086775-A2 | LUMEN-EXPOSED MOLECULES AND METHODS FOR TARGETED DELIVERY | UTAH VENTURES II, L.P. (US) | 2005-09-22 | — | — | WO | claimed |
| WO-2003093819-A1 | BIOMOLECULE DIAGNOSTIC DEVICES AND METHOD FOR PRODUCING BIOMOLECULE DIAGNOSTIC DEVICES | KIMBERLY-CLARK WORLDWIDE, INC. (US) | 2003-11-13 | — | — | WO | claimed |
| WO-1997043645-A1 | ANTIBODIES DIRECTED AGAINST DITHIOCARBAMATES | MEDINOX, INC. (US) | 1997-11-20 | — | — | WO | claimed |
| CN-118339252-A | Resin composition, and coverlay film, adhesive sheet, resin-equipped metal foil, metal-clad laminate or printed wiring board using the same | 尼关工业株式会社 | 2024-07-12 | — | — | CN | disclosed |
| WO-2024107755-A1 | SINGLE-MOLECULE PEPTIDE SEQUENCING USING DITHIOESTER AND THIOCARBAMOYL AMINO ACID REACTIVE GROUPS | GLYPHIC BIOTECHNOLOGIES, INC. (US) | 2024-05-23 | — | — | WO | disclosed |
| EP-4370555-A1 | METHODS OF PREVENTING PROTEIN AGGREGATION | TrueBinding, Inc. (US) | 2024-05-22 | — | — | EP | disclosed |
| EP-4352105-A2 | ANTI-GAL3 ANTIBODIES AND METHODS OF USE FOR INSULIN RESISTANCE | TrueBinding, Inc. (US) | 2024-04-17 | — | — | EP | disclosed |
| EP-4329804-A1 | ANTI-GAL3 ANTIBODY FORMULATIONS AND METHODS OF USE THEREOF | TrueBinding, Inc. (US) | 2024-03-06 | — | — | EP | disclosed |
| CN-117561080-A | anti-GAL 3 antibody formulations and methods of use thereof | 真和制药有限公司 | 2024-02-13 | — | — | CN | disclosed |
| US-5630996-A | Two-step pretargeting methods using improved biotin-active agent conjugates | NEORX CORPORATION (US) | 1997-05-20 | — | — | US | disclosed |
| US-5608060-A | DIAGNOSIS AND TREATMENT OF CANCER; DRUG DELIVERY TO TARGET CELLS | NEORX CORPORATION (US) | 1997-03-04 | — | — | US | disclosed |
| WO-1995010302-A1 | CELLULAR AND SERUM PROTEIN ANCHORS AND CONJUGATES | REDCELL, INC. (US) | 1995-04-20 | — | — | WO | disclosed |
| EP-0646019-A1 | PRETARGETING METHODS AND COMPOUNDS | NEORX CORPORATION (US) | 1995-04-05 | — | — | EP | disclosed |
| WO-1993025240-A2 | PRETARGETING METHODS AND COMPOUNDS | NEORX CORPORATION (US) | 1993-12-23 | — | — | WO | disclosed |
| EP-0032539-B1 | LIFTING CORRECTION ELEMENT FOR PRINTED CHARACTERS | International Business Machines Corporation (US) | 1985-03-20 | — | — | EP | disclosed |